Phlexglobal wins landmark deal with UCB for global electronic trial master file solution

08-Sep-2009 - United Kingdom

Phlexglobal has signed a landmark contract with global biopharmaceutical company UCB to implement a complete trial master file management solution. The new contract is worth £12 million, over the next five years, and will see Phlexglobal employ up to 30 new staff.

Nicola Murgatroyd, Phlexglobal's founder and chief executive officer, commented: “The UCB contract win is a major achievement for Phlexglobal and will support our rapid expansion, both in the UK and US.”

As part of the contract, Phlexglobal will provide electronic and paper trial master file (TMF) management services for UCB global operations. This will include centralising UCB’s historical and ongoing global clinical study files from Phase I through to Phase IV using Phlexglobal’s PhlexEview solution.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances